Skip to main content
. 2018 Jul 13;9(54):30304–30323. doi: 10.18632/oncotarget.25717

Figure 2. Effect of PJLME on morphology of MDA-MB-231, MCF-7 and HaCaT cells.

Figure 2

(A) Control MDA-MB-231cells (B) PJLME treated MDA-MB-231 Cells (C) Control MCF-7 cells (D) PJLME treated MCF-7 cells (E) Control HaCaT cells (F) PJLME treated HaCaT cells. The cells were treated with PJLME (16.8 μg/mL) and vehicle control (DMSO 0.1% ) for 72h and the images were digitizedat10X magnification using an inverted Nikon microscope equipped with a digital camera.